Journal Watch
The Form of PD Linked with the Best Health-related Quality of Life is…
In China, at least, cycler PD wins the day. Compared to 64 people who started and stayed on CAPD, 64 others who switched to use a cycler had about the same HRQOL at the start of a study. One year later, those using cyclers had significantly better scores on most of the KDQOL subscales.
Read the abstract » | (added 2022-02-14)
PD Helps Kidney Function Recovery
PD is known to help preserve residual kidney function. A study of 981 people on PD and 12,619 on HD in Taiwan looked at which option was more likely to help incident dialyzors recover function. Nearly 5% did recover their kidney function within 3 years—with a better chance for those who did PD.
Read the abstract » | (added 2022-02-14)
Tags: PD, HD, Kidney Function Recovery
Omental Procedures During PD Catheter Placement and PD Success
Removing or fixing the omentum in place may reduce the risk of PD catheter malfunction. A review of 15 studies found less catheter failure, obstruction, or removal when omental procedures were done.
Read the abstract » | (added 2022-02-14)
What We Don’t Know About Insulin Dosing for PD or HD Can Hurt Us
After 60 years of dialysis, we have a good sense of how to adjust insulin doses for PD and HD, right? Wrong. Even though diabetes is the leading cause of kidney failure, a systematic review of 11 articles found little information about insulin management.
Read the abstract » | (added 2022-02-14)
Tags: Insulin Dose, PD, HD, Insulin Management
COVID Anxiety Less of a Problem for Home Dialyzors
A single center survey of 98 home HD and 43 PD patients in Toronto found high rates of satisfaction with dialysis, little depression or anxiety or fears of caregiver burden, and few signs of burden. There was “no indication of a negative psychosocial impact from the pandemic, despite the increased social isolation,” reported the authors.
Read the abstract » | (added 2022-02-14)
Tags: Covid 19, Depression, Anxiety, Caregiver Burden
Must PD Stop when Residual Kidney Function is Gone?
Not necessarily. In a small, physiological study (n=15) of anuric CAPD patients with low Kt/V, fluid status, dietary intake, and nitrogen removal were all assessed. All were able to maintain good nutritional status, with no symptoms of nitrogen retention and good volume control.
Read the abstract » | (added 2022-02-14)
Tags: PD, Residual Kidney Function, CAPD, Kt/V, Fluid Status, Dietary Intake, Nitrogen Removal, Volume Control
Incremental PD with Residual Kidney Function: Safe and Effective
Compared to 42 people who started full-dose PD, 54 who began incremental PD between 2015 and 2019 tended to be female, not have diabetes, and have more residual kidney function. PD technique survival, peritonitis, and hospitalization were about the same for both groups.
Read the abstract » | (added 2022-01-14)
Tags: Incremental PD, Residual Kidney Function, Full dose PD, Technique Survival
Can Urgent PD Starts Use Incremental PD?
In a retrospective study of 169 people who began PD, 111 started with incremental PD, while the remaining 58 began full-dose PD. Both groups were similar at the start. After 1 year, the full-dose group was on a higher PD prescription and had significantly higher PD adequacy numbers. Residual kidney function, blood pressure, anemia, and bone mineral correction were similar in both groups.
Read the abstract » | (added 2022-01-14)
Tags: Incremental PD, Full dose PD, PD Prescription, PD Adequacy, Urgent start Peritoneal Dialysis, Residual Kidney Function
Plastic vs. Metal Hemodialysis Needles: An International Nurse Survey
Plastic HD needles help prevent infiltration and hematomas, especially in elbow-located, new, or fragile fistulae—yet most countries continue to use cheaper metal needles. A nurse survey found strong resistance to plastic cannulae among respondents. Reduction in adverse access events may reduce costs, staff time, and patient distress.
Read the abstract » | (added 2022-01-14)
Tags: Plastic HD Needles, Plastic Cannulae, Infiltration, Hematomas
Cost of the Quanta SC+ in the UK
In the United Kingdom, in-center hemodialysis costs more than £36,350 per year, which includes patient transport. Annual costs for use of the SC+ were estimated to be less: £26,642 for thrice weekly HD as home self-care, £30,235 for standard in-center HD; and £29,866 for 5x/weekly HD as home self-care.
Read the abstract » | (added 2022-01-14)
Tags: Quanta SC+, Hemodialysis Costs